Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 2/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.57 |
| ▸ | MAPT | P10636 | 3/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.55 |
| ▸ | FEN1 | P39748 | 1/20 | 0.55 |
| ▸ | NPC1 | O15118 | 2/20 | 0.55 |
| ▸ | RAB9A | P51151 | 2/20 | 0.55 |
| ▸ | CES2 | O00748 | 2/20 | 0.54 |
| ▸ | CES1 | P23141 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.53 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.53 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.53 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.53 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.53 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.53 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.53 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17187853 | 1.00 | GSK3B (0.64) | GSK3BL3MBTL1MAPTSMN1; SMN2ERCC5 | |
| SCHEMBL7214228 | 1.00 | GSK3B (0.64) | GSK3BL3MBTL1MAPTSMN1; SMN2ERCC5 | |
| SCHEMBL11305427 | 0.94 | L3MBTL1 (0.68) | GSK3BL3MBTL1MAPTSMN1; SMN2ERCC5 | |
| Acetic Acid SCHEMBL27667375 | 0.94 | GSK3B (0.57) | GSK3BL3MBTL1MAPTSMN1; SMN2ERCC5 | |
| SCHEMBL27759976 | 0.92 | GSK3B (0.55) | GSK3BL3MBTL1MAPTSMN1; SMN2ERCC5 | |
| Paroxypropione SCHEMBL27862463 | 0.92 | NPC1 (0.65) | GSK3BL3MBTL1MAPTSMN1; SMN2NPC1 | |
| SCHEMBL11780135 | 0.90 | GSK3B (0.57) | GSK3BL3MBTL1MAPTSMN1; SMN2ERCC5 | |
| SCHEMBL6142809 | 0.88 | MMP1 (0.59) | GSK3BL3MBTL1MAPTSMN1; SMN2NPC1 | |
| SCHEMBL8051337 | 0.87 | SMN1; SMN2 (0.70) | GSK3BL3MBTL1MAPTSMN1; SMN2NPC1 | |
| Fluorobenzene SCHEMBL27628207 | 0.85 | MAPT (0.58) | GSK3BL3MBTL1MAPTSMN1; SMN2ERCC5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 650 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240091111-A1 | METHODS OF MASKING OFF-TASTES | GIVAUDAN SA (CH) | 2024-03-21 | — | — | US | claimed |
| EP-4297716-A1 | METHODS OF MASKING OFF-TASTES | Givaudan SA (CH) | 2024-01-03 | — | — | EP | claimed |
| CN-111574569-B | Coordination compound of rhodium, preparation method and application thereof | 安徽师范大学 | 2023-04-18 | — | — | CN | claimed |
| WO-2022180141-A1 | METHODS OF MASKING OFF-TASTES | GIVAUDAN SA (CH) | 2022-09-01 | — | — | WO | claimed |
| CN-212605364-U | Conveyer is used in processing of p-chlorophenylacetone | 襄阳市宇爵化工有限公司 | 2021-02-26 | — | — | CN | claimed |
| CN-111574569-A | Coordination compound of rhodium, preparation method and application thereof | 安徽师范大学 | 2020-08-25 | — | — | CN | claimed |
| CN-101500996-B | (3-amino-1,2,3,4-tetrahydro-9h-carbazol-9-yl)-acetic acid derivatives | ACTELION PHARMACEUTICALS LTD | 2012-07-04 | — | — | CN | claimed |
| WO-2008056377-A2 | POLYMORPHIC FORMS OF RIMONABANT | CADILA HEALTHCARE LIMITED (IN) | 2008-05-15 | — | — | WO | claimed |
| EP-0107198-B1 | USE OF 2-HYDROXY-2-METHYL-(P-CHLOROPROPIONPHENONE) AS A PHOTOINITIATOR | CIBA-GEIGY AG (CH) | 1987-07-08 | — | — | EP | claimed |
| US-3956153-A | MINIMIZATION OF UNDERCOOLING | BIO-MEDICAL SCIENCES, INC. (US) | 1976-05-11 | — | — | US | claimed |
| JP-10087490-A | — | — | None | — | — | JP | disclosed |
| WO-2025215121-A1 | HEDGEHOG ACYLTRANSFERASE INHIBITORS | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2025-10-16 | — | — | WO | disclosed |
| US-12281058-B2 | Manganese catalysts and their use in hydrogenation of ketones | UNIVERSITY COURT OF THE UNIVERSITY OF ST ANDREWS (GB) | 2025-04-22 | — | — | US | disclosed |
| CN-119390551-A | Method for realizing methoxymethylation under photocatalysis condition | 浙江工业大学 | 2025-02-07 | — | — | CN | disclosed |
| US-20250042831-A1 | PROCESS FOR PREPARING 5-CHLORO-2, 3-DIHYDRO-1H-INDEN-1-ONE | ADAMA MAKHTESHIM LTD. (IL) | 2025-02-06 | — | — | US | disclosed |
| US-4009157-A | POLYESTER FOAMING AGENTS, FREE RADICAL CATALYSTS | PENNWALT CORPORATION (US) | 1977-02-22 | — | — | US | disclosed |
| US-3980581-A | NUCLEATING AGENTS, SOLID SOLUTIONS | BIO-MEDICAL SCIENCES, INC. (US) | 1976-09-14 | — | — | US | disclosed |
| US-3956153-A | MINIMIZATION OF UNDERCOOLING | BIO-MEDICAL SCIENCES, INC. (US) | 1976-05-11 | — | — | US | disclosed |
| US-3956316-A | PROGESTATIONAL AND SALT-RETAINING AGENTS | HOFFMANN-LA ROCHE INC. (US) | 1976-05-11 | — | — | US | disclosed |
| US-3946612-A | Temperature indicating compositions | BIO-MEDICAL SCIENCES, INC. (US) | 1976-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12281058-B2 | Manganese catalysts and their use in hydrogenation of ketones | CYC1, SCO2, MT-CO3 | GSK3B 3681/4885L3MBTL1 1159/4885MAPT 4683/4885 |
| US-20250042831-A1 | PROCESS FOR PREPARING 5-CHLORO-2, 3-DIHYDRO-1H-INDEN-1-ONE | SI, IDO1, CYP4B1 | GSK3B 1400/4885L3MBTL1 4742/4885MAPT 4473/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.